Selected Publications
Laken SJ, Jackson PE, Kinzler KW, Vogelstein B, Strickland PT, Groopman JD, Friesen MD. Genotyping by mass spectrometric analysis of short DNA fragments. Nature Biotechnol 16:1352-1356, 1998.
Strickland PT, Kang DH. Urinary 1-hydroxypyrene and other PAH metabolites as biomarkers of exposure to environmental PAH in air particulate matter. Toxicol Let 108:191-199, 1999.
Sithisarankul P, Weaver VM, Davoli CT, Strickland PT. Urinary 5-aminolevulinic acid in lead-exposed children. Biomarkers 4:281-289, 1999.
Lee CK, Cho SH, Kang JW, Lee SJ, Ju YS, Sung JH, Strickland PT, Kang DH. Comparison of three analytical methods for 1-hydroxypyrene-glucuronide in urine after non-occupational exposure to polycyclic aromatic hydrocarbons. Toxicol Let 108:209-215, 1999.
Sithisarankul P, Cadorette M, Davoli CT, Serwint JR, Chisolm JJ, Strickland PT. Plasma 5-amino- levulinic acid concentration and lead exposure in children. Environ Res 80:41-49, 1999.
Helzlsouer KJ, Alberg AJ, Huang HY, Hoffman S, Strickland PT, Brock JW, Burse VW, Needham LL, Bell DA, Lavigne J, Yager JD, Comstock GW. Serum concentrations of organochlorine compounds and the subsequent development of breast cancer. Cancer Epidemiol Biomarkers Preven 8:525-532, 1999.
Zavala AG, Lancaster T, Groopman JD, Strickland PT, Chandrasegaran S. Phage display of ScFv peptides recognizing thymidine(6-4)thymidine photoproduct. Nucleic Acids Res 28:e24, 2000.
Carlson MA, Bargeron CB, Benson RC, Fraser AB, Phillips TE, Velky JT, Groopman JD, Strickland PT. An automated handheld biosensor for aflatoxin. Biosensors Bioelectron 14:841-848, 2000.
Park SK, Yoo KY, Lee SJ, Kim SU, Ahn SH, Noh DY, Choe KJ, Strickland PT, Hirvonen A, Kang DH. Alcohol consumption, glutathione S-transferase M1 and T1 genetic polymorphisms and breast cancer risk. Pharmacogenetics 10:301-309, 2000.
Cho SH, Kang JW, Ju YS, Sung JH, Lee CK, Lee YS, Strickland PT, Kang DH. Use of urinary PAH metabolites to assess PAH exposure intervention among coke oven workers. J Occup Health 42:138-143, 2000.
Roth MJ, Qiao YL, Rothman N, Tangrea JA, Dawsey SM, Wang GQ, Cho SH, Kang DH, Taylor PR, Strickland PT. High urine 1-hydroxypyrene glucuronide concentrations in Linxian, China, an area of high risk for squamous esophageal cancer. Biomarkers 6:381-386, 2001.
Strickland PT, Qian Z, Friesen M, Rothman N, Sinha R. Measurement of 2-amino-1-methyl-6-phenylimidazo (4,5-b)pyridine (PhIP) in acid-hydrolyzed urine by high performance liquid chromatography with fluorescence detection. Biomarkers 6:313-325, 2001
Friesen M, Rothman N, Strickland PT. Concentration of 2-amino-1-methyl-6-phenylimidazo-(4,5-b)- pyridine (PhIP) in urine and alkali-hydrolyzed urine after consumption of charbroiled beef. Cancer Letters 173:43-51, 2001.
Wang JS, Abubaker S, He X, Strickland PT, Groopman JD. Development of an aflatoxin B1-lysine adduct specific monoclonal antibody for human exposure studies. Appld Environ Microbiol 67:2712-2717,2001
Yim DS, Park SK, Yoo KY, Yoon KS, Chung HH, Ahn SH, Noh DY, Choe KJ, Jang IJ, Shin SG, Strickland PT, Hirvonen A, Kang DH. Relationship between the val158met polymorphism of catechol O-methyl transferase and breast cancer risk. Pharmacogenetics 11:279-286, 2001.
Goodman JE, Lavigne JA, Wu K, Helzlsouer KJ, Strickland PT, Selhub J, Yager JD. COMT genotype, micronutrients in the folate metabolic pathway and risk for breast cancer. Carcinogenesis 22:1661-1665, 2001.
Whitmore SE, Potten CS, Chadwick CA, Strickland PT, Morison WL. Effect of photoreactivating light on UV radiation-induced alterations in human skin. Photodermatol Photoimmunol Photomed 17:213-217, 2001.
Strickland PT, Qian Z, Friesen M, Rothman N, Sinha R. Metabolites of 2-amino-1-methyl-6-phenylimidazo(4,5-b)pyridine (PhIP) in human urine after consumption of charbroiled or fried meat. Mutation Research 506:163-173, 2002.
Lee KH, Lee JM, Ha M, Choi JW, Cho SH, Hwang ES, Park CG, Strickland PT, Hirvonen A, Kang DH. Influence of polymorphism of GSTM1 gene on association between glycophorin A mutant frequency and urinary PAH metabolites in incineration workers. J Toxicol Environ Health 65:355-363, 2002.
Kim SU, Park SK, Yoo KY, Yoon KS, Choi JY, Seo JS, Park WY, Kim JH, Noh DY, Ahn SH, Choe KJ, Strickland PT, Hirvonen A, Kang DH. XRCC1 genetic polymorphism and breast cancer risk. Pharmacogenetics 12:335-338, 2002.
Ishibe N, Sinha R, Hein DW, Kulldorff M, Strickland P, Fretland AJ, Chow WH, Kadlubar FF, Lang NP, Rothman N. Genetic polymorphisms in heterocyclic amine metabolism and risk of colorectal adenomas. Pharmacogenetic 12:145-150, 2002.
Sutter CH, Qian Z, Mammen JS, Strickland PT, Sutter TR. Genotyping human cytochrome P450 1B1 variants. Methods Enzymol 375:53-58, 2002.
Cantor KP, Strickland PT, Brock JW, Bush D, Helzlsouer K, Needham LL, Zahm SH, Comstock GW, Rothman N. Risk of non-Hodgkin's lymphoma and pre-diagnostic serum organchlorines: ß-hexachlorocyclohexane, chlordane/heptachlor-related compounds, dieldrin, and hexachloro-benzene. Env Health Perspec 111:179-183, 2003
Park SK, Kang DH, Noh DY, Kang HJ, Ahn SH, Choe KJ, Strickland PT, Hirvonen A, Yoo KY. Reproductive factors, glutathione S-transferase M1 and T1 genetic polymorphisms and breast cancer risk. Breast Cancer Research Treatment 78:89-96, 2003.
Lee KH, Ichiba M, Zhang JS, Tomokuni K, Hong YC, Ha M, Lee JM, Ha M, Kwon HJ, Koh SB, Choi HR, Lee KH, Park CG, Cho SH, Hirvonen A, Strickland PT, Vermeulen R, Hayes RB, Kang DH. Multiple biomarker study in painters in a shipyard in Korea. Mutation Research 540:89-98, 2003.
Mammen JS, Pittman GS, Li Y, Abou-Zahr F, Bejjani BA, Bell DA, Strickland PT, Sutter TR. Single amino acid mutations, but not common polymorphisms, decrease the activity of CYP1B1 against (-)benzo[a]pyrene-7R-trans- 7,8-dihydrodiol. Carcinogenesis 24:1247-1255, 2003.
Lai CH, Liou SH, Shih TS, Tsai PJ, Chen HS, Buckley T, Strickland P, Jaakkola JJK. Urinary 1-hydroxypyrene-glucuronide as a biomarker of exposure to traffic exhausts among highway toll station workers. Arch Environ Health 59:61-69, 2004.
Jackson PE, Kuang SY, Wang JB, Strickland PT, Munoz A, Kensler TW, Qian GS, Groopman JD. Prospective detection of codon 249 mutations in plasma of hepatocellular carcinoma patients. Carcinogenesis 24:1657-1663, 2003.
Kim JH, Sherman ME, Curriero FC, Guengerich FP, Strickland PT, Sutter TR. Expression of cytochromes P450 1A1 and 1B1 in human lung from smokers, non-smokers, and ex-smokers. Toxicol Appld Pharmacol 199:210-219, 2004.
Alberg AJ, Daudt A, Huang HY, Hoffman SC, Comstock GW, Helzlsouer KJ, Strickland PT, Bell DA. N-Acetyl transferase 2 (NAT2) genotypes, cigarette smoking and the risk of breast cancer. Cancer Detect Preven 28:187-193, 2004.
Kamanger F, Strickland PT, Pourshams A, Malekzadeh R, Boffetta P, Roth MJ, Abnet CC, Saadatian-Elahi M, Rakhshani N, Brennan P, Etemadi A, Dawsey SM. High exposure to polycyclic aromatic hydrocarbons may contribute to high risk of esophageal cancer in northeastern Iran. Anticancer Research 25:425-428, 2005.
Mammen JS, Kleiner HE, DiGiovanni J, Sutter TS, Strickland PT. Coumarins are competitive inhibitors of cytochrome P450 1B1, with equal potency for allelic variants. Pharmacogenetics Genomics 15:183-188, 2005.
Pourshams A, Saadatian-Elahi M, Nouraie M, Malekshah AF, Rakhshani N, Salahi R, Yoonessi A, Semnani S, Islami F, Sotoudeh M, Fahimi S, Sadjadi AR, Nasrollahzadeh D, Aghcheli K, Kamanger F, Abnet CC, Saidi F, Sewram V, Strickland PT, Dawsey SM, Brennan P, Boffetta P, Malekzadeh R. Golestan cohort study of oesophageal cancer: feasibility and first results. Brit J Cancer 92:176-181, 2005.
Lai CH, Liou SH, Shih TS, Tsai PJ, Chen JS, Yang T, Jaakkola JJK, Strickland PT. Exposure to traffic exhausts and oxidative DNA damage. Occupat Environ Med 62:216-222, 2005.
Sastry C, Whitmore E, Breysse P, Morrison WL, Strickland PT. The effect of clinical UVA/B exposures on urinary urocanic acid isomer levels in individuals with Caucasian skin types (II/III). Dermatol Online J 11:1, 2005.
Gaffney SH, Curriero FC, Strickland PT, Glass GE, Helzlsouer KJ, Breysse PN. Influence of geographical location in modeling blood pesticide levels in a community surrounding an EPA Superfund site. Environ Health Perspec 113:1712-1716, 2005.
Sinha R, Kulldorff M, Gunter MJ, Strickland P, Rothman N. Dietary benzo[a]pyrene and risk of colorectal adenoma. Cancer Epidemiol Biomarkers Prev 14:2030-2034, 2005.
Kang DH, Lee KH, Lee KM, Kwon HJ, Hong YC, Cho SH, Strickland PT. Design issues in cross-sectional biomarkers studies:Urinary biomarkers of PAH exposure and oxidative stress. Mutation Research 592:138-146, 2005.
Genkinger JM, Platz EA, Hoffman S, Strickland P, Comstock GW, Helzlsouer KJ. C47T polymorphism in manganese superoxide dismutase (MnSOD), antioxidant intake and all-cause, cancer and cardiovascular disease mortality. Mech Aging Develop 127:371-377, 2006.
Gunier R, Reynolds P, Hurley S, Yerabati S, Hertz A, Strickland P, Horn-Ross P, Anton-Culver H, Bernstein L, Deapen D, Peel D, Pinder R, Ross RK, West D, Wright WE, Ziogas A. Estimating exposure to polycyclic aromatic hydrocarbons: a comparison of survey, biological monitoring and GIS-based methods. Cancer Epidemiol Biomarkers Preven 15:1376-1381, 2006
Fagundes RB, Abnet CC, Strickland PT, Kamanger F, Roth MJ, Taylor PR, Dawsey SM. Higher urine 1-hydroxypyrene glucuronide (1-OHPG) is associated with smoking tobacco, preparing barbeque, and drinking mate in healthy subjects from Rio Grande do Sul, Brazil. BMC Cancer 6:139, 2006.
Abnet CC, Fagundes RB, Strickland PT, Kamangar F, Roth MJ, Taylor PR, Dawsey SM. The influence of genetic polymorphisms in Ahr, CYP1A1, CYP1A2, CYP1B1, GST M1, GST T1, and UGT1A1 on urine 1-hyrdoxypyrene glucuronide concentrations in healthy subjects from Rio Grande do Sul, Brazil. Carcinogenesis 28:112-117, 2007.
Visvanathan K, Crum RM, , Strickland PT, You X, Ruczinski I, Berndt SL, Alberg AJ, Hoffman SC, Comstock GW, Bell DA, Helzlsouer KJ. Alcohol dehydrogenase genetic polymorphisms, low-to-moderate alcohol consumption, and risk of breast cancer. Alcohol Clin Exp Res 31:467-476, 2007.
Engel LS, Laden F, Anderson A, Strickland PT, Blair A, Needham LL, Barr DB, Wolff MS, Helzlsouer K, Hunter DJ, Lan Q, Cantor KP, Comstock GW, Brock JW, Bush D, Hoover RN, Rothman N. Polychlorinated biphenyl levels in peripheral blood and non-Hodgkin’s lymphoma: a report from three cohorts. Cancer Research 67:5545-5552, 2007.
Gunter MJ, Divi RL, Kulldorff M, Vermeulen R, Haverkos KJ, Kuo MM, Strickland PT, Poirier MC, Rothman N, Sinha R. Leukocyte polycyclic aromatic hydrocarbon-DNA adduct formation and colorectal adenoma. Carcinogenesis 28:1426-1429, 2007.
Huang HY, Thuita L, Strickland PT, Hoffman SC, Comstock GW, Helzlsouer KJ. Frequencies of single nucleotide polymorphisms in genes regulating inflammatory responses in a community-based population. BMC Genet 8:7, 2007.
Gallicchio L, Kalesan B, Huang HY, Strickland P, Hoffman SC, Helzlsouer KJ. Genetic polymorphisms of peroxisome proliferator-activated receptors and the risk of cardiovascular morbidity and mortality in a community-based cohort in Wahington County, Maryland. PPAR Research 2008:276581. PubMed PMID: 18288282; PubMed Central PMCID: PMC2233806.
Chen J, Ruczinski I, Jorgensen TJ, Yenokyan G, Yao Y, Alani R, Liégeois NJ, Hoffman SC, Hoffman-Bolton J, Strickland PT, Helzlsouer KJ, Alberg AJ. Nonmelanoma skin cancer and risk for subsequent malignancy. J Natl Cancer Inst 100:1215-1222, 2008.
Gallicchio L, Chang H, Christo DK, Thuita L, Huang HY, Strickland P, Ruczinski I, Hoffman SC, Helzlsouer KJ. Single nucleotide polymorphisms in inflammation-related genes and mortality in a community-based cohort in Washington County, Maryland. Am J Epidemiol 167:807-813, 2008.
Lee KH, Vermeulen R, Lenters V, Cho SH, Strickland PT, Kang D. Determinants of urinary 1-hydroxypyrene glucuronide in South Korean children. Int Arch Occup Environ Health 82(8):961-968, 2009. PubMed PMID: 19020893.
Suwan-ampai P, Navas-Acien A, Strickland PT, Agnew J. Involuntary tobacco smoke exposure and urinary levels of polycyclic aromatic hydrocarbons in the United States, 1999 to 2002. Cancer Epidemiol Biomarkers Prev 18(3):884-893, 2009. PubMed PMID: 19258471.
Gallicchio L, Chang HH, Christo DK, Thuita L, Huang HY, Strickland P, Ruczinski I, Clipp S, Helzlsouer KJ. Single nucleotide polymorphisms in obesity-related genes and all-cause and cause-specific mortality: a prospective cohort study. BMC Med Genet 10:103, 2009. PubMed PMID: 19818126; PubMed Central PMCID: PMC2763854.
Wheless L, Ruczinski I, Alani RM, Clipp S, Hoffman-Bolton J, Jorgensen TJ, Liégeois NJ, Strickland PT, Alberg AJ. The association between skin characteristics and skin cancer prevention behaviors. Cancer Epidemiol Biomarkers Prev 18:2613-2619, 2009. PubMed PMID: 19755654; PubMed Central PMCID: PMC2759861.
Chae YK, Huang HY, Strickland P, Hoffman SC, Helzlsouer K. Genetic polymorphisms of estrogen receptors alpha and beta and the risk of developing prostate cancer. PLoS One. 4:e6523, 2009. PubMed PMID: 19654868; PubMed Central PMCID: PMC2715882.
Lam TK, Ruczinski I, Helzlsouer K, Shugart YY, Li KE, Clipp S, Strickland PT, Alberg AJ. Copy number variants of GSTM1 and GSTT1 in relation to lung cancer risk in a prospective cohort study. Ann Epidemiol 19:546-552, 2009. PubMed PMID: 19394866; PubMed Central PMCID: PMC2720160.
Lin MH, Liou SH, Chang CW, Huang IH, Strickland PT, Lai CH. An engineering intervention resulting in improvement in lung function and change in urinary 8-hydroxydeoxyguanosine among foundry workers in Taiwan. Intern Arch Occup Environ Health Sep 24, 2010 [Epub ahead of print] PubMed PMID: 20865274.
Hofmann JN, Dong LM, Strickland PT, Shu XO, Yang G, Ji BT, Rothman N, Chow WH, Gao YT, Zheng W, Kamanger F. Polycyclic aromatic hydrocarbons: Determinants of urinary 1-hydroxypyrene glucuronide concentration and relation to colorectal cancer in the Shanghai Women’s Health Study. (in press).
Islami F, Boffetta P, van Schooten FJ, Strickland PT, Phillips D, Pourshams A, Malekshah AFT, Godschalk R, Jafari E, Etemadi A, Kamanger F, Straif K, Moller H, Schuz J, Malekzadeh R. Exposure to polycyclic aromatic hydrocarbons among never smokers in Golestan Province, a high incidence area for esophageal cancer in Iran – A cross-sectional biomarker study in two seasons. (in press)
